References

Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc

10.1016/j.chom.2016.07.006 · 2016 · External reference

Neuropsychiatric disturbances in mild cognitive impairment: a scientometric analysis

10.1016/j.arr.2023.102129 · 2023 · External reference

Global patterns and trends in colorectal cancer incidence and mortality

10.1136/gutjnl-2015-310912 · 2017 · External reference

Association of Fusobacterium nucleatum with specific T-cell subsets in the colorectal carcinoma microenvironment

10.1158/1078-0432.ccr-20-4009 · 2021 · External reference

Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression

10.1080/19490976.2021.1987780 · 2021 · External reference

Fusobacterium nucleatum - symbiont, opportunist and oncobacterium

10.1038/s41579-018-0129-6 · 2019 · External reference

The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention

10.1038/s41416-018-0264-x · 2018 · External reference

Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer

10.1126/science.aal5240 · 2017 · External reference

Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma

10.1101/gr.126516.111 · 2012 · External reference

Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance

10.1016/j.jconrel.2023.09.028 · 2023 · External reference

Colorectal cancer-global burden, trends, and geographical variations

10.1002/jso.24578 · 2017 · External reference

Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses

10.1096/fj.07-9492lsf · 2008 · External reference

Unraveling the role of Fusobacterium nucleatum in colorectal cancer: molecular mechanisms and pathogenic insights

10.3390/cancers17030368 · 2025 · External reference

Phytochemical interventions for post-traumatic stress disorder: a cluster co-occurrence network analysis using CiteSpace

10.1016/j.joim.2023.06.006 · 2023 · External reference

The gut microbiota and colon cancer

10.1126/science.aaw2367 · 2019 · External reference

Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack

10.1016/j.immuni.2015.01.010 · 2015 · External reference

Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1

10.1080/2162402x.2019.1581531 · 2019 · External reference

Fusobacterium nucleatum in colorectal cancer relates to immune response differentially by tumor microsatellite instability status

10.1158/2326-6066.cir-18-0174 · 2018 · External reference

Hallmarks of cancer: new dimensions

10.1158/2159-8290.cd-21-1059 · 2022 · External reference

Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck

10.1002/cncr.34338 · 2022 · External reference

Intratumoral levels and prognostic significance of Fusobacterium nucleatum in cervical carcinoma

10.18632/aging.104188 · 2020 · External reference

Fusobacterium nucleatum: ecology, pathogenesis and clinical implications

10.1038/s41579-025-01237-z · 2026 · External reference

Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer

10.1016/j.chom.2023.04.010 · 2023 · External reference

How to use bibliometric methods in evaluation of scientific research? An example from Finnish schizophrenia research

10.1080/08039480801961667 · 2008 · External reference

Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment

10.1016/j.chom.2013.07.007 · 2013 · External reference

Analysis of three-dimensional printing strategies for meniscus/articular disc repair and regeneration

10.1089/ten.teb.2024.0233 · 2024 · External reference

Fusobacterium nucleatum promotes colorectal cancer cell to acquire stem cell-like features by manipulating lipid droplet-mediated Numb degradation

10.1002/advs.202105222 · 2022 · External reference

Frontier and hot topics in electrochemiluminescence sensing technology based on CiteSpace bibliometric analysis

10.1016/j.bios.2021.113932 · 2022 · External reference

Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

10.1136/gutjnl-2015-310101 · 2016 · External reference

Fusobacterium nucleatum and T cells in colorectal carcinoma

10.1001/jamaoncol.2015.1377 · 2015 · External reference

The role of Fusobacterium nucleatum in oral and colorectal carcinogenesis

10.3390/microorganisms11092358 · 2023 · External reference

Global burden of cancers attributable to infections in 2012: a synthetic analysis

10.1016/s2214-109x(16)30143-7 · 2016 · External reference

What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases

10.3390/microorganisms7010014 · 2019 · External reference

Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1

10.15252/embr.201847638 · 2019 · External reference

The microbiome and human cancer

10.1126/science.abc4552 · 2021 · External reference

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

10.3322/caac.21660 · 2021 · External reference

The gut microbial metabolite formate exacerbates colorectal cancer progression

10.1038/s42255-022-00558-0 · 2022 · External reference

An empirical dietary pattern associated with the gut microbial features in relation to colorectal cancer risk

10.1053/j.gastro.2024.07.040 · 2024 · External reference

Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer

10.1016/j.ccell.2025.02.023 · 2025 · External reference

Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer

10.1038/s41591-019-0406-6 · 2019 · External reference

Gut microbiota in colorectal cancer development and therapy

10.1038/s41571-023-00766-x · 2023 · External reference

Gut microbiota in colorectal cancer: mechanisms of action and clinical applications

10.1038/s41575-019-0209-8 · 2019 · External reference

Knowledge mapping of immune thrombocytopenia: a bibliometric study

10.3389/fimmu.2023.1160048 · 2023 · External reference

Microbe-driven immune suppression in colorectal cancer: the Fusobacterium nucleatum playbook

10.3389/fimmu.2026.1795703 · 2026 · External reference

Global colorectal cancer burden in 2020 and projections to 2040

10.1016/j.tranon.2021.101174 · 2021 · External reference

Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization

10.1080/19490976.2021.1980347 · 2021 · External reference

Worldwide research trends in Crohn’s disease treatment over the past 2 decades: a bibliometric analysis

10.3389/fphar.2024.1441785 · 2024 · External reference

Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer

10.1038/s41591-019-0458-7 · 2019 · External reference

Knowledge atlas of antibody-drug conjugates on CiteSpace and clinical trial visualization analysis

10.3389/fonc.2022.1039882 · 2022 · External reference

Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy

10.1016/j.cell.2017.07.008 · 2017 · External reference

The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis

10.1038/s41564-024-01784-w · 2024 · External reference

The association between periodontal disease and adverse pregnancy outcomes: a bibliometric analysis from 2000 to 2023

10.3389/fmed.2025.1526406 · 2025 · External reference